Rowlandmiller & Partners’s Bio-Rad Laboratories Class A BIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $159K | Sell |
660
-8
| -1% | -$1.93K | 0.03% | 155 |
|
|
2025
Q1 | $163K | Sell |
668
-185
| -22% | -$45.1K | 0.03% | 151 |
|
|
2024
Q4 | $280K | Sell |
853
-30
| -3% | -$9.86K | 0.06% | 130 |
|
|
2024
Q3 | $295K | Sell |
883
-95
| -10% | -$31.8K | 0.06% | 130 |
|
|
2024
Q2 | $267K | Sell |
978
-75
| -7% | -$20.5K | 0.06% | 127 |
|
|
2024
Q1 | $364K | Sell |
1,053
-18
| -2% | -$6.23K | 0.08% | 119 |
|
|
2023
Q4 | $346K | Sell |
1,071
-20
| -2% | -$6.46K | 0.08% | 117 |
|
|
2023
Q3 | $391K | Sell |
1,091
-136
| -11% | -$48.7K | 0.1% | 106 |
|
|
2023
Q2 | $465K | Sell |
1,227
-235
| -16% | -$89.1K | 0.11% | 105 |
|
|
2023
Q1 | $700K | Sell |
1,462
-255
| -15% | -$122K | 0.17% | 87 |
|
|
2022
Q4 | $725K | Hold |
1,717
| – | – | 0.18% | 84 |
|
|
2022
Q3 | $716K | Buy |
1,717
+65
| +4% | +$27.1K | 0.19% | 78 |
|
|
2022
Q2 | $818K | Buy |
1,652
+75
| +5% | +$37.1K | 0.21% | 73 |
|
|
2022
Q1 | $888K | Buy |
1,577
+240
| +18% | +$135K | 0.21% | 74 |
|
|
2021
Q4 | $1.01M | Buy |
1,337
+674
| +102% | +$509K | 0.23% | 72 |
|
|
2021
Q3 | $299K | Sell |
663
-674
| -50% | -$304K | 0.1% | 97 |
|
|
2021
Q2 | $861K | Buy |
1,337
+115
| +9% | +$74.1K | 0.21% | 79 |
|
|
2021
Q1 | $698K | Buy |
1,222
+293
| +32% | +$167K | 0.18% | 79 |
|
|
2020
Q4 | $542K | Buy |
+929
| New | +$542K | 0.15% | 87 |
|
|
2020
Q3 | – | Sell |
-663
| Closed | -$299K | – | 143 |
|
|
2020
Q2 | $299K | Buy |
+663
| New | +$299K | 0.1% | 97 |
|